《市評》港股續升 成交3,239億創三個月高 港交所及券商股起舞
市場觀望美國關稅及中國外長王毅將於今日(11日)下午會見美國國務卿魯比奧消息,受科網及金融股帶動,港股今日向上。美股道指及納指隔晚(10日)各升0.4%及0.1%,撰文之時,美國2年期債券孳息升至3.887%,美國10年期債券孳息升至4.383%,美匯指數0.17%至97.82,道指期貨最新跌238點或0.53%,納指期貨最新跌107點或0.5%。上證綜指全日近平收報3,510點,深證成指升0.6%,滬深兩市成交額共逾1.71萬億元人民幣。
港匯再觸發弱方兌換保證,金管局在紐約時段買入132.82億港元。恆指高開4點後升幅擴大,午後曾升477點一度高見24,506點,隨後升幅收窄,全日升111點或0.5%,收24,139點;國指升19點或0.2%,報8,687點;恆生科技指數升31點或0.6%,收5,248點。大市全日成交總額3,239.5億元(錄自4月10日(當日成交額3,955億元)以來最高水平))近三個月高。今日北水交易總成交額1,819.91億元,而南向資金今日淨流入17.44億元(上日淨流入29.02億元)。「消費股F4」回吐,泡泡瑪特(09992.HK)及毛戈平(01318.HK)跌4.1%及4.8%,老鋪黃金(06181.HK)跌11.4%,蜜雪(02097.HK)跌2%。此外,半新股週六福(06168.HK)收跌7.4%、泰國椰子水品牌「if」母企IFBH(06603.HK)跌5.8%。
恆指本週累升223點或0.9%,國指本週累升78點或0.9%,恆生科指本週累升32點或0.6%。美國總裁特朗普向現有關稅稅率執行期限由7月9日延至8月1日,並已致函多國國家通知最新對等關稅稅率,當中日本及韓國進口產品徵收25%關稅,而市場亦憧憬內地未來或推出進一步刺激經濟措施。
【港交所攀升 券商股炒高】
穩定幣熱潮延伸至內地券商股,上海市國資委就圍繞加密貨幣與穩定幣發展趨勢及應對策略召開中心組學習會。國泰海通(02611.HK)及中信建投(06066.HK)炒高10.5%及7.6%,中金(03908.HK)及廣發(01776.HK)升逾4%。中州證券(01375.HK)炒高47%。其他券商股抽升,南華金融(00619.HK)及立橋(08350.HK)各飆升101%及47%,交銀國際(03329.HK)及申萬宏源香港(00218.HK)升5%及6.3%。
港交所(00388.HK)攀升近3%收425.6元。內險股太保(02601.HK)升4.9%,中國平安(02318.HK)及財險(02328.HK)升2.3%及2.8%。據內媒報道,國家財政部引導保險資金長期穩健投資,進一步加強國有商業保險公司長週期考覈,財政部發布引導保險資金長期穩健投資,進一步加強國有商業保險公司長週期考覈的通知。《辦法》中經營效益類指標的「淨資產收益率」由「3年週期指標+當年度指標」相結合的考覈方式調整爲「當年度指標+3年週期指標+5年週期指標」相結合的考覈方式。
【升股千二隻 藥明康德彈】
港股今日市寬向好,主板股票的升跌比率爲30比19(上日爲31比20),上升股份1,244只(升幅3.3%),恆指成份股今日46只股份上升,下跌股35只,升跌比率爲54比41(上日60比39)。大市今日錄沽空353.86億元,佔可沽空股份成交額2,906.97億元的12.173%(上日爲13.467%)。
醫藥股藥明康德(02359.HK)預告半年純利增1.02倍,股價升10.5%。同系藥明生物(02269.HK)升3.7%、藥明合聯(02268.HK)升6.7%。摩根士丹利預計藥明康德股價未來30天內股價上漲,因該公司公佈2025年上半年收入約208億元人民幣,按年增長21%,調整後純利約63億元,按年增長44%,分別超出大摩預期約5%和15%。2025年次季收入和利潤按年增長分別達20%和48%,遠高於公司全年持續經營業務收入增長10%至15%的指引,並指藥明康德H股相較於其他藥明系股票估值更具吸引力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.